Targeting EMT in cancer with repurposed metabolic inhibitors

V Ramesh, T Brabletz, P Ceppi - Trends in cancer, 2020 - cell.com
Epithelial-to-mesenchymal transition (EMT) determines the most lethal features of cancer,
metastasis formation and chemoresistance, and therefore represents an attractive target in …

Celecoxib in cancer therapy and prevention–review

N Tołoczko-Iwaniuk… - Current Drug …, 2019 - ingentaconnect.com
Background and Objectives: It is generally accepted that inflammatory cells found in the
tumor microenvironment are involved in the neoplastic process, promoting cell proliferation …

Inflammation, fibrosis and cancer: mechanisms, therapeutic options and challenges

B Wu, QH Sodji, AK Oyelere - Cancers, 2022 - mdpi.com
Simple Summary Inflammation is like the proverbial double-edged sword. Controlled short-
term inflammation could be a protective response while uncontrolled inflammation sustains …

New insights on COX-2 in chronic inflammation driving breast cancer growth and metastasis

HJ Hugo, C Saunders, RG Ramsay… - Journal of mammary …, 2015 - Springer
The medicinal use of aspirin stretches back to ancient times, before it was manufactured in
its pure form in the late 19th century. Its accepted mechanistic target, cyclooxygenase (COX) …

Anti-tumor activity of non-steroidal anti-inflammatory drugs: cyclooxygenase-independent targets

JL Liggett, X Zhang, TE Eling, SJ Baek - Cancer letters, 2014 - Elsevier
Non-steroidal anti-inflammatory drugs (NSAIDs) are used extensively for analgesic and
antipyretic treatments. In addition, NSAIDs reduce the risk and mortality to several cancers …

GINS2 facilitates epithelial‐to‐mesenchymal transition in non‐small‐cell lung cancer through modulating PI3K/Akt and MEK/ERK signaling

X Liu, L Sun, S Zhang, S Zhang… - Journal of Cellular …, 2020 - Wiley Online Library
Non‐small‐cell lung cancer (NSCLC) is a cancer with high morbidity and mortality. We
aimed to define the effect of Go‐Ichi‐Ni‐San complex subuint 2 (GINS2) acting on NSCLC …

Ursolic acid simultaneously targets multiple signaling pathways to suppress proliferation and induce apoptosis in colon cancer cells

J Wang, L Liu, H Qiu, X Zhang, W Guo, W Chen, Y Tian… - PloS one, 2013 - journals.plos.org
Ursolic acid (UA), a natural pentacyclic triterpenoid carboxylic acid distributed in medical
herbs, exerts antitumor effects and is emerging as a promising compound for cancer …

Epithelial–mesenchymal transition in human gastric cancer cell lines induced by TNF‐α‐inducing protein of Helicobacter pylori

T Watanabe, A Takahashi, K Suzuki… - … journal of cancer, 2014 - Wiley Online Library
Helicobacter pylori strains produce tumor necrosis factor‐α (TNF‐α)‐inducing protein, Tipα
as a carcinogenic factor in the gastric epithelium. Tipα acts as a homodimer with 38‐kDa …

Arctigenin represses TGF-β-induced epithelial mesenchymal transition in human lung cancer cells

Y Xu, Z Lou, SH Lee - Biochemical and biophysical research …, 2017 - Elsevier
Arctigenin (ARC) is a lignan that is abundant in Asteraceae plants, which show anti-
inflammatory and anti-cancer activities. The current study investigated whether ARC affects …

TGF-β1 downregulates COX-2 expression leading to decrease of PGE2 production in human lung cancer A549 cells, which is involved in fibrotic response to TGF-β1

E Takai, M Tsukimoto, S Kojima - PLoS One, 2013 - journals.plos.org
Transforming growth factor-ß1 (TGF-β1) is a multifunctional cytokine that is involved in
various pathophysiological processes, including cancer progression and fibrotic disorders …